These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 21536180

  • 21. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.
    Miller L, Chartrand S, Koenig M, Goulet JR, Rich É, Chin AS, Chartrand-Lefebvre C, Abrahamowicz M, Senécal JL, Grodzicky T.
    Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008
    [Abstract] [Full Text] [Related]

  • 22. Definitions and diagnosis of pulmonary hypertension.
    Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB.
    J Am Coll Cardiol; 2013 Dec 24; 62(25 Suppl):D42-50. PubMed ID: 24355641
    [Abstract] [Full Text] [Related]

  • 23. Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis.
    McLaughlin V, Humbert M, Coghlan G, Nash P, Steen V.
    Rheumatology (Oxford); 2009 Jun 24; 48 Suppl 3():iii25-31. PubMed ID: 19487219
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
    Le Pavec J, Girgis RE, Lechtzin N, Mathai SC, Launay D, Hummers LK, Zaiman A, Sitbon O, Simonneau G, Humbert M, Hassoun PM.
    Arthritis Rheum; 2011 Aug 24; 63(8):2456-64. PubMed ID: 21538327
    [Abstract] [Full Text] [Related]

  • 26. Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study.
    Overbeek MJ, Groepenhoff H, Voskuyl AE, Smit EF, Peeters JW, Vonk-Noordegraaf A, Spreeuwenberg MD, Dijkmans BC, Boonstra A.
    Respir Res; 2008 Oct 01; 9(1):68. PubMed ID: 18828919
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Screening of pulmonary hypertension in a Spanish cohort of patients with systemic sclerosis].
    García Hernández FJ, Castillo Palma MJ, Montero Mateos E, González León R, López Haldón JE, Sánchez Román J.
    Med Clin (Barc); 2016 Jan 01; 146(1):1-7. PubMed ID: 26169331
    [Abstract] [Full Text] [Related]

  • 31. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Yuan YP, Yuan P, Su YL, Jiang R, Zhang R, He J, Qiu HL, Luo CJ, Liu JM, Gong SG, Wang L, Zhao QH.
    Clin Rheumatol; 2022 Jun 01; 41(6):1675-1686. PubMed ID: 35099674
    [Abstract] [Full Text] [Related]

  • 32. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
    Hachulla E, Launay D, Mouthon L, Sitbon O, Berezne A, Guillevin L, Hatron PY, Simonneau G, Clerson P, Humbert M, French PAH-SSc Network.
    Chest; 2009 Nov 01; 136(5):1211-1219. PubMed ID: 19429720
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis.
    Duarte AC, Cordeiro A, Loureiro MJ, Ferreira F.
    Clin Rheumatol; 2020 May 01; 39(5):1687-1691. PubMed ID: 31965379
    [Abstract] [Full Text] [Related]

  • 38. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L, Caporali R, Klersy C, Ghio S, Albertini R, Scelsi L, Moratti R, Bonino C, Montecucco C.
    J Rheumatol; 2010 Oct 01; 37(10):2064-70. PubMed ID: 20634241
    [Abstract] [Full Text] [Related]

  • 39. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Strand V, Furst DE, Distler O, Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis.
    J Rheumatol; 2011 Nov 01; 38(11):2419-27. PubMed ID: 21965635
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.